Results 81 to 90 of about 952,320 (325)

Conformal Graph Directed Markov Systems on Carnot Groups [PDF]

open access: yesMemoirs of the American Mathematical Society, 2016
We develop a comprehensive theory of conformal graph directed Markov systems in the non-Riemannian setting of Carnot groups equipped with a sub-Riemannian metric.
V. Chousionis   +2 more
semanticscholar   +1 more source

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

open access: yesMolecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani   +14 more
wiley   +1 more source

Metric dimension of fullerene graphs

open access: yesElectronic Journal of Graph Theory and Applications, 2019
A resolving set W is a set of vertices of a graph G ( V ,  E ) such that for every pair of distinct vertices u ,  v  ∈  V ( G ) , there exists a vertex w  ∈  W satisfying d ( u ,  w ) ≠  d ( v ,  w ) .
S. Akhter, R. Farooq
semanticscholar   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine   +10 more
wiley   +1 more source

Schrijver graphs and projective quadrangulations

open access: yes, 2016
In a recent paper [J. Combin. Theory Ser. B}, 113 (2015), pp. 1-17], the authors have extended the concept of quadrangulation of a surface to higher dimension, and showed that every quadrangulation of the $n$-dimensional projective space $P^n$ is at ...
A. Hatcher   +8 more
core   +2 more sources

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

open access: yesMolecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop   +10 more
wiley   +1 more source

Dynamics around the Site Percolation Threshold on High-Dimensional Hypercubic Lattices

open access: yes, 2018
Recent advances on the glass problem motivate reexamining classical models of percolation. Here, we consider the displacement of an ant in a labyrinth near the percolation threshold on cubic lattices both below and above the upper critical dimension of ...
Biroli, Giulio   +2 more
core   +1 more source

Investigating the Diversity of Tuberculosis Spoligotypes with Dimensionality Reduction and Graph Theory [PDF]

open access: gold, 2022
Gaëtan Senelle   +3 more
openalex   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

open access: yesMolecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy